GlassScriptPhysician profile
Juan Ronderos
NPI 1407875016
$38,903.36
in general payments reported to CMS, 2019-2025
31 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,276 · 2020: $5,260 · 2021: $18K · 2022: $6,113 · 2023: $907 · 2024: $97.93 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $16,351.09 | 2019-2022 | |
| Orthofix Medical, INC. | $13,136.97 | 2019-2021 | |
| Curiteva, INC. | $4,530.74 | 2019-2023 | |
| Globus Medical, INC. | $2,109.30 | 2019-2022 | |
| Baxter Healthcare | $568.70 | 2019-2022 | |
| Spinal Elements, INC. | $457.90 | 2021-2022 | |
| Abbvie INC. | $312.76 | 2022-2025 | |
| Medtronic, INC. | $208.61 | 2021-2025 | Adaptix Interbody System With Titan Nanolock Surface Technology, Mazor X System, Kyphon Express II Kyphopak Tray |
| Gt Medical Technologies, INC | $186.06 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $127.40 | 2023 | |
| Novocure INC. | $125.00 | 2020 | |
| Kls-Martin L.P. | $117.50 | 2021 | |
| Zimmer Biomet Holdings, INC. | $97.57 | 2019-2021 | |
| Depuy Synthes Sales INC. | $88.40 | 2022-2023 | Synthecel, Matrixneuro |
| Providence Medical Technology, INC. | $71.43 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axis Spine Technologies INC. | $51.72 | 2021 | |
| Arbor Pharmaceuticals, INC. | $45.17 | 2021 | |
| Integrity Implants INC. | $44.41 | 2019 | |
| Nevro Corp. | $37.45 | 2021 | |
| Abbott Laboratories | $37.24 | 2022-2024 | Eterna |
| Csl Behring | $30.66 | 2019 | |
| Medtronic USA, INC. | $29.61 | 2019-2020 | |
| Lemaitre Vascular, INC. | $24.46 | 2022 | |
| Radius Health, INC. | $21.52 | 2022 | |
| Brainlab, INC. | $18.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.75 | 2022 | |
| Irras USA, INC. | $14.00 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.33 | 2019 | |
| Avanir Pharmaceuticals, INC. | $13.18 | 2022 | |
| Stimwave Technologies Incorporated | $11.39 | 2020 | |
| Si-Bone, INC. | $6.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Ronderos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.